Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
Clinical trial NCT04614246 · TERMINATED
Trial details
- NCT number
- NCT04614246
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2022-01-17
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.